Skip to content

Laparoscopic surgery for ovarian cancer

Laparoscopic surgery for ovarian, fallopian tubal, and peritoneal cancer

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1070240120
Enrollment
450
Registered
2025-03-03
Start date
2025-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian, fallopian tube and peritoneal cancer Laparoscopy, ovarian cancer, fallopian tube cancer, peritoneal cancer

Interventions

We perform laparoscopic surgery for ovarian, fallopian tube and peritoneal cancer, which is not yet covered by insurance in Japan.

Sponsors

Kobayashi Eiji
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Ovarian cancer judged to be resectable (including fallopian tube cancer, peritoneal cancer and borderline malignant ovarian tumours) 2) Ovarian cancer deemed resectable after preoperative treatment (including fallopian tube cancer, peritoneal cancer and borderline malignant ovarian tumours) 3) Patients with an ECOG performance status of 0 to 2 4) Patients with adequate major organ function. (Laboratory tests must be performed within 28 days prior to scheduled surgery) Neutrophil count > 1,000 \/mm3 Platelet count > 100,000 \/mm3 AST (GOT), ALT (GPT) less than 100 IU/L Total serum bilirubin less than 1.5 mg\/dl Serum creatinine less than 1.5 mg/dl Electrocardiogram within normal limits or asymptomatic and not requiring treatment (in patients without heart disease or serious arrhythmias)

Exclusion criteria

Exclusion criteria: 1) Patients who do not meet the above selection criteria. 2) Patients with serious complications. Examples: serious cardiac or cerebrovascular disease, diabetes or hypertension difficult to control with HbA1c > 8.5%, pulmonary fibrosis, interstitial pneumonia, haemorrhage, active peptic ulcer or serious neurological disease are excluded. 3) Patients who are expected to have difficulty completing the study or follow-up afterwards, or who are deemed unsuitable by the physician in charge.

Design outcomes

Primary

MeasureTime frame
Perioperative complications within 30 days of the date of surgery requiring medical intervention

Contacts

Public ContactMasakazu Nishida

Fuculty of Medicine, Obstetrics and Gyneclogy

nishifa@oita-u.ac.jp+81-97-586-5922

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026